Benign essential blepharospasm

Guy J. Ben Simon*, John D. McCann

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


With more research and better understanding of the etiology of BEB, many more choices are now available in the medical and surgical management of this condition. In addition to Botulinum toxin injection, which has revolutionized treatment of the disease, feasible options include pharmacotherapy, myectomy, chemodenervation, and chemomyectomy. Various combinations of these treatments can provide effective therapy for most of patients with blepharospasm.

Original languageEnglish
Pages (from-to)49-75
Number of pages27
JournalInternational Ophthalmology Clinics
Issue number3
StatePublished - Jun 2005
Externally publishedYes


Dive into the research topics of 'Benign essential blepharospasm'. Together they form a unique fingerprint.

Cite this